| Acute Myeloid Leukemia with KMT2A Rearrangement studied in …STUDIED_INderived18 of 18show fewer |
|---|
| → studied in | NCT05886049Phase 1 · recruiting A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease · condition mapped ONTOLOGY_EXACT · 18 trials mapped (5 active) | — | — | Acute Myeloid Leukemia with KMT2A Rearrangement | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Acute Myeloid Leukemia with a Variant KMT2A Rearrangement | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06222580Phase 1 · recruiting SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation · condition mapped ONTOLOGY_EXACT · 18 trials mapped (5 active) | — | — | Acute Myeloid Leukemia with KMT2A Rearrangement | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03701295Phase 1/Phase 2 · completed Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00383474Phase 1 · completed Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 18 trials mapped (5 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |